MORELLI, GIAN LUCA
MORELLI, GIAN LUCA
DMED - DIPARTIMENTO DI MEDICINA
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements
2024-01-01 Bonifacio, M.; Scaffidi, L.; Miggiano, M. C.; Facchinelli, D.; Tosoni, L.; Pezone, S.; Griguolo, D.; Ciotti, G.; Danini, M.; Bernardelli, A.; Bresciani, R.; Cavraro, M.; Crosera, L.; De March, E.; Dell'Eva, M.; Dorotea, L.; Frison, L.; Furlani, L.; Gianesello, I.; Lovato, E.; Marchetti, E.; Morelli, G.; Mullai, R.; Pizzano, U.; Zoletto, S.; Fanin, R.; Krampera, M.; Trentin, L.; Calistri, E.; Carli, G.; Binotto, G.; Tiribelli, M.
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience (Annals of Hematology, (2024), 103, 2, (443-448), 10.1007/s00277-023-05578-8)
2024-01-01 Tosoni, L.; Liberi, M.; Morelli, G.; Zannier, M. E.; Lazzarotto, D.; Fili, C.; Simeone, E.; Battaglia, G.; Callegari, C.; Fanin, M.; Damiani, D.; Fanin, R.; Tiribelli, M.
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study
2025-01-01 Tosoni, L.; Di Giusto, S.; Morelli, G.; Bergnach, M.; Callegari, C.; Stella, R.; Zaja, F.; Schwab, A.; Wolfler, A.; Toffoletti, E.; Damiani, D.; Fanin, R.; Tiribelli, M.
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response
2023-01-01 Tosoni, L.; Fabbro, D.; Pizzano, U.; Mullai, R.; Morelli, G.; Franzoni, A.; Damante, G.; Toffoletti, E.; Damiani, D.; Fanin, R.; Tiribelli, M.
The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia
2024-01-01 Tosoni, L.; Morelli, G. L.; Tomadini, G.; Lazzarotto, D.; Fili, C.; Simeone, E.; Zannier, M. E.; Callegari, C.; Fanin, M.; Battaglia, G.; Bergnach, M.; Damiani, D.; Fanin, R.; Tiribelli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements | 1-gen-2024 | Bonifacio, M.; Scaffidi, L.; Miggiano, M. C.; Facchinelli, D.; Tosoni, L.; Pezone, S.; Griguolo, D.; Ciotti, G.; Danini, M.; Bernardelli, A.; Bresciani, R.; Cavraro, M.; Crosera, L.; De March, E.; Dell'Eva, M.; Dorotea, L.; Frison, L.; Furlani, L.; Gianesello, I.; Lovato, E.; Marchetti, E.; Morelli, G.; Mullai, R.; Pizzano, U.; Zoletto, S.; Fanin, R.; Krampera, M.; Trentin, L.; Calistri, E.; Carli, G.; Binotto, G.; Tiribelli, M. | |
| Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience (Annals of Hematology, (2024), 103, 2, (443-448), 10.1007/s00277-023-05578-8) | 1-gen-2024 | Tosoni, L.; Liberi, M.; Morelli, G.; Zannier, M. E.; Lazzarotto, D.; Fili, C.; Simeone, E.; Battaglia, G.; Callegari, C.; Fanin, M.; Damiani, D.; Fanin, R.; Tiribelli, M. | |
| High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study | 1-gen-2025 | Tosoni, L.; Di Giusto, S.; Morelli, G.; Bergnach, M.; Callegari, C.; Stella, R.; Zaja, F.; Schwab, A.; Wolfler, A.; Toffoletti, E.; Damiani, D.; Fanin, R.; Tiribelli, M. | |
| JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response | 1-gen-2023 | Tosoni, L.; Fabbro, D.; Pizzano, U.; Mullai, R.; Morelli, G.; Franzoni, A.; Damante, G.; Toffoletti, E.; Damiani, D.; Fanin, R.; Tiribelli, M. | |
| The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia | 1-gen-2024 | Tosoni, L.; Morelli, G. L.; Tomadini, G.; Lazzarotto, D.; Fili, C.; Simeone, E.; Zannier, M. E.; Callegari, C.; Fanin, M.; Battaglia, G.; Bergnach, M.; Damiani, D.; Fanin, R.; Tiribelli, M. |